Systemic lupus erythematosus or lupus is a polygenic autoimmune disease characterized by high levels of anti-nuclear autoantibodies, and several cellular abnormalities involving B-cells. myeloid cells and other lineages. The genetic basis of lupus remains to be solved. Although the approximate positions of several disease susceptibility loci in murine lupus have been elucidated in many different models, the identity of the culprit genes within the identified loci remain elusive. In particular, this is true of the BXSB strain that develops lupus spontaneously. We have recently identified 2 potential candidate genes that appear attractive as culprit genes for lupus in this model, based on expression differences, intriguing sequence polymorphisms and demonstrated functional differences. The goal of this proposal is to test the candidacy of these 2 molecules as potential culprit genes for BXSB lupus, and to ascertain how these genes might influence the function of B-cells and myeloid cells, using in vitro and in vivo approaches. In addition, we will assess the origins and pathogenic contributions of heightened SDF1/CXCR4 activity in lupus. Given that very little is currently known about the genetics of lupus, or about why B-cells and myeloid cells are hyperactive in lupus, the proposed studies could greatly boost our understanding of this disease. Gaining a clear understanding of the genetic and molecular basis of lupus is essential before more targeted therapeutic strategies can be devised for this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI039824-13
Application #
7862350
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
13
Fiscal Year
2009
Total Cost
$253,284
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Luo, Wei; Mayeux, Jessica; Gutierrez, Toni et al. (2014) A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J Immunol 193:909-920
Cuda, Carla M; Misharin, Alexander V; Gierut, Angelica K et al. (2014) Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation. J Immunol 192:5548-60
Dozmorov, Igor; Dominguez, Nicolas; Sestak, Andrea L et al. (2013) Evidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients. PLoS One 8:e71397
Gutierrez, Toni; Mayeux, Jessica M; Ortega, Sterling B et al. (2013) IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. Eur J Immunol 43:382-93
Cuda, Carla M; Agrawal, Hemant; Misharin, Alexander V et al. (2012) Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis Rheum 64:808-20
Gutierrez, Toni; Halcomb, Kristina E; Coughran, Alanna J et al. (2010) Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur J Immunol 40:1897-905
Wang, Andrew; Guilpain, Philippe; Chong, Benjamin F et al. (2010) Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum 62:3436-46
Jacob, Chaim O; Zhu, Jiankun; Armstrong, Don L et al. (2009) Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 106:6256-61
Wang, Andrew; Fairhurst, Anna-Marie; Tus, Katalin et al. (2009) CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol 182:4448-58
Fairhurst, Anna-Marie; Mathian, Alexis; Connolly, John E et al. (2008) Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice. Eur J Immunol 38:1948-60

Showing the most recent 10 out of 30 publications